Global Angiostomy Cannula Market: Overview
A cannula is any tube inserted into the body cavities for targeted therapy. Angiostomy is a medical procedure whereby surgical balloons and plastic cannulas are used to open up a blocked artery. These cannulas need to be made of neutral material so as to not elicit inflammation from blood cells. This innovation has revolutionized the way heart disease is treated globally, from often unsuccessful medical intervention to better surgical procedures that ensure better recovery rates.
Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6818
The global incidence of heart disease is increasing by the day, notes TMRR. A fast paced lifestyle where people have little time to care for their own needs is to be implicated for the same, coupled with rising global age. Chronic illnesses increase with age as do heart diseases. The current COVID-19 pandemic is expected to have an adverse effect of global heart health by virtue of post infection complications. Hence, the future for the angiostomy cannulas market seems bright, especially over the forecast period of 2019 to 2029.
Global Angiostomy Cannula Market: Competitive Landscape
A number of manufacturers are involved in the production of angiostomy cannulas. This makes the market scenario fragmented. Some of these players are-
- Smith & Nephew
- Maquet Holding B.V. & Co. KG.
- Sorin Group
- Edward Lifescience Corporation
- Medtronic plc
- Terumo Corporation
- Medline Industries, Inc.
- Cardinal Health
- Boston Scientific Corporation
- Teleflex Incorporated
- Conmed Corporation
- Dolphin Surgicals
- Micromed International
- Goodhealth Inc.
- BioTek Instruments, Inc.
These manufacturers recognize the rising demand for angiostomy cannulas and should increase production by acquisition of smaller production facilities and investing in innovation laboratories around the globe. Moreover, market outreach requires that individuals and healthcare settings alike understand the importance of this recent innovation.
Global Angiostomy Cannula Market: Key Trends and Drivers
- Global incidence of chronic diseases is rising as people live better and age further than their ancestors. 57% of the global population is estimated to be affected by one or more chronic illness by 2050, according to the World Health Organization. Cardiovascular diseases (CVD) make up an important part of this disease profile. Over 480 million cases of CVD were reported in the United States alone in 2017, an increase of 28.5% over the past 10 years. Medical intervention is failing drastically in such cases, and angiostomy offers hope in this regard. Thus, the angiostomy cannula market should grow steadily in the future.
- Healthcare spending is increasing globally. People are demanding standard healthcare from their governments as innovations and medical success stories are made public. Riding on this trend, the angiostomy cannulas market should grow concomitantly in the future. COVID-19 has been identified as an illness with not just immediate implications but also long term effects. One of these is the occurrence of blood clots a number of days after recovery. The cardiovascular system is at increased risk from such an onslaught, and angiostomy cannulas should be demanded increasingly in the near future to tackle complications of this pandemic.
Global Angiostomy Cannula Market: Regional Analysis
North America and Europe are currently global leaders in the angiostomy cannulas market. This can be attributed to the presence of a robust healthcare infrastructure that supports innovations. Also, a rising geriatric population is expected to steer this market to growth in the coming years.
The Asia Pacific region (APAC) is expected to register the fastest growth in this market given that regional governments are increasing investment in the healthcare sector. An adoption of western styles of living is pushing people over the cliff of chronic illnesses, which gives a steady growth impetus to the angiostomy cannulas market.
- Cardiac Cannula
- Vascular Cannula
- Arthroscopy Cannula
- Dermatology Cannula
- Nasal Cannula
- Floating Spinal Cannula
- Vitreoretinal Cannula,
- Hysterosalpingography Cannula
- Cardiovascular Surgery
- Oxygen Therapy
- Orthopedic Surgery
- Diabetes Treatment
- General Surgery
- Cosmetic/Plastic Surgery
By End User:
- Ambulatory Surgical Centers
- Blood Banks
- Home Healthcare Facilities
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6818
About TMR Research:
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
3739 Balboa St # 1097,
San Francisco, CA 94121